[Clinical aspects of drug interactions with selected antiplatelet drugs].
Physiological and pathological knowledge of blood platelets effectively permit to inhibition their adhesion and aggregation processes. Antiplatelet drugs are very important therapeutic groups in prevention of many cardiovascular system diseases. They characterize with high effectiveness tested in many clinical studies and small amount of side effects. However during the interaction with other simultaneously applied drugs one may observe decrease of therapeutic tolerancy, diminishing of its effectiveness and appearing of adverse effects. In this work we considered clinical results of interactions of some antiplatelet drugs (acetylosalicylic acid, ticlopidin, clopidogrel, heparin).
Kostka-Trabka
E
E
Zakładu Farmakologii Klinicznej Katedry Farmakologii CM UJ w Krakowie.
Woroń
J
J
D004347:Drug Interactions; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000494:pharmacology*
D010975:Platelet Aggregation Inhibitors